2014 annual financial data
Marker Therapeutics 2014 Net margin
Marker Therapeutics 2014 net margin with verified reported values.
Direct answer
Net margin was Not calculable.
Operating income was -3,370,927 USD and net income was -30,883,096 USD.
Operating cash flow was -2,187,145 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -3,370,927 USD
- Net income
- -30,883,096 USD
- Operating cash flow
- -2,187,145 USD